Last update :
01/10/2024
Antibiotic   Cefazolin sodium  
injection
Eye-drops
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Acef Italy
Ancef United States of America
Basocef Germany
Biofazolin Poland
Brizolina Spain
Cecan Peru
Cefabiozim Italy
Cefacidal Chile, Colombia, Luxembourg, Mexico, Morocco, Netherlands
Cefadin India
Cefamezin Tunisia
Cefazil Italy
Cefozin Turkey
Cromezin Italy
Eqizolin Turkey
Fazoplex Spain
Intrazolina Spain
Kefzol Austria, Belgium, Switzerland
Kurgan Spain
Nefazol Italy
Recef Italy
Sefamax Turkey
Sefazol Turkey
Sicef Italy
Tasep Spain
Tecfazolina Spain
Totacef Italy
Vifazolin Greece
Zepilen Thailand
Zolicef Austria
Zolival Spain
Stability in solutions   injection   Stability in solutions : Cefazolin sodium     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass Water for Injection 400 mg/ml -20°C Protect from light
182 Day
581
Biological analysis

Glass NaCl 0,9% or Glucose 5% 10 mg/ml 25°C Light
48 Hour
418
Level of evidence D

Glass NaCl 0,9% or Glucose 5% 400 mg/ml -20°C Protect from light
182 Day
581
Biological analysis

Glass Sodium chloride 0,9% 10 mg/ml 2-8°C Protect from light
28 Day
1452
Level of evidence D

Glass Sodium chloride 0,9% 10 mg/ml 25°C Not specified
7 Day
1452
Level of evidence D

Glass Glucose 5% 5 mg/ml -20°C Protect from light
182 Day
581
Biological analysis

Polyvinyl chloride Water for Injection 73,2 mg/ml -20°C Protect from light
30 Day
440
Level of evidence D

Polyvinyl chloride NaCl 0,9% or Glucose 5% 10 mg/ml -20°C Protect from light
48 Hour
582
Biological analysis

Polyvinyl chloride NaCl 0,9% or Glucose 5% 20 mg/ml -20°C Protect from light
30 Day
573
Biological analysis

Polyvinyl chloride NaCl 0,9% or Glucose 5% 20 mg/ml 5°C Protect from light
30 Day
3230
Level of evidence A

Polyvinyl chloride NaCl 0,9% or Glucose 5% 40 mg/ml 5°C Protect from light
30 Day
3230
Level of evidence A

Polyvinyl chloride Glucose 5% 10 mg/ml 4°C Protect from light
30 Day
656
Level of evidence D

Polyvinyl chloride Glucose 5% 20 mg/ml -20°C Protect from light
30 Day
576
Biological analysis

Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,5 mg/ml 25°C Not specified
8 Day
2372
Level of evidence B

Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,5 mg/ml 37°C Not specified
24 Hour
2372
Level of evidence B

Polyvinyl chloride Dianéal® PD1 1.5% glucose (Baxter) 0,5 mg/ml 4°C Not specified
14 Day
2372
Level of evidence B

Polyvinyl chloride Dianéal® PD1 4.25% glucose (Baxter) 0,5 mg/ml 25°C Not specified
8 Day
2372
Level of evidence B

Polyvinyl chloride Dianéal® PD1 4.25% glucose (Baxter) 0,5 mg/ml 37°C Not specified
24 Hour
2372
Level of evidence B

Polyvinyl chloride Dianéal® PD1 4.25% glucose (Baxter) 0,5 mg/ml 4°C Not specified
14 Day
2372
Level of evidence B

Polyvinyl chloride Dianéal® PD2 1.5% glucose (Baxter) 0,333 mg/ml 25°C Not specified
11 Day
1979
Level of evidence D

Polyvinyl chloride Dianéal® PD2 1.5% glucose (Baxter) 0,333 mg/ml 37°C Not specified
24 Hour
1979
Level of evidence D

Polyvinyl chloride Dianéal® PD2 1.5% glucose (Baxter) 0,333 mg/ml 4°C Not specified
20 Day
1979
Level of evidence D

Polyvinyl chloride Dianéal® PD2 1.5% glucose (Baxter) 0,333 mg/ml 4°C Not specified
20 Day
1979
Level of evidence D

Polyvinyl chloride Extraneal® (Baxter) 0,5 mg/ml 25°C Not specified
7 Day
1805
Level of evidence D

Polyvinyl chloride Extraneal® (Baxter) 0,5 mg/ml 25°C Protect from light
7 Day
3888
Level of evidence D

Polyvinyl chloride Extraneal® (Baxter) 0,5 mg/ml 37°C Not specified
24 Hour
1805
Level of evidence D

Polyvinyl chloride Extraneal® (Baxter) 0,5 mg/ml 37°C Protect from light
24 Hour
3888
Level of evidence D

Polyvinyl chloride Extraneal® (Baxter) 0,5 mg/ml 4°C Not specified
30 Day
1805
Level of evidence D

Polyvinyl chloride Extraneal® (Baxter) 0,5 mg/ml 4°C Protect from light
14 Day
3888
Level of evidence D

Polyolefine Sodium chloride 0,9% 10 mg/ml 2-8°C Protect from light
28 Day
1452
Level of evidence D

Polyolefine Sodium chloride 0,9% 10 mg/ml 25°C Not specified
7 Day
1452
Level of evidence D

Ethylene vinyl acetate Sodium chloride 0,9% 10 mg/ml 23°C Protect from light
5 Day
1840
Level of evidence B+

Ethylene vinyl acetate Sodium chloride 0,9% 10 mg/ml 4°C Protect from light
30 Day
1840
Level of evidence B+

Polypropylen Syringe Water for Injection 100 mg/ml 5°C Protect from light
30 Day
3230
Level of evidence A

Polypropylen Syringe Water for Injection 200 mg/ml 5°C Protect from light
30 Day
3230
Level of evidence A

Polypropylen Syringe Water for Injection 333 mg/ml -20°C Protect from light
270 Day
574
Biological analysis

Polypropylen Syringe NaCl 0,9% or Glucose 5% 125 mg/ml 20-25°C Light
24 Hour
4634
Level of evidence C+

Polypropylen Syringe Sodium chloride 0,9% 50 mg/ml 25°C Not specified
7 Day
1814
Level of evidence B

Polypropylen Syringe Sodium chloride 0,9% 50 mg/ml 5°C Not specified
22 Day
1814
Level of evidence B

Polyisoprene elastomer NaCl 0,9% or Glucose 5% 12,5 mg/ml 35°C Not specified
12 Hour
4247
Level of evidence A+

Polyisoprene elastomer NaCl 0,9% or Glucose 5% 12,5 mg/ml 4°C Not specified
72 Hour
4247
Level of evidence A+

Polyisoprene elastomer NaCl 0,9% or Glucose 5% 25 mg/ml 35°C Not specified
12 Hour
4247
Level of evidence A+

Polyisoprene elastomer NaCl 0,9% or Glucose 5% 25 mg/ml 4°C Not specified
72 Hour
4247
Level of evidence A+

Polyisoprene elastomer NaCl 0,9% or Glucose 5% 5 & 40 mg/ml 25°C Not specified
24 Hour
604
Manufacturer's stability data

Polyisoprene elastomer NaCl 0,9% or Glucose 5% 5 & 40 mg/ml 4°C Protect from light
10 Day
604
Manufacturer's stability data


  Mentions Légales